Combination of | |
---|---|
Amlodipine | Calcium channel blocker |
Valsartan | Angiotensin II receptor antagonist |
Clinical data | |
Trade names | Exforge |
AHFS/ Drugs.com | Professional Drug Facts |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
KEGG | |
CompTox Dashboard ( EPA) | |
(verify) |
Amlodipine/valsartan, sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains amlodipine, as the besilate, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist. [3] This combination is usually well tolerated and effective for the reduction of blood pressure. [4]
The combination was approved for medical use in the United States in June 2007. [5]
The combination is also available with included hydrochlorothiazide (Exforge HCT), for people who need a three-drug regimen to manage their blood pressure. [6] [7] It was approved for medical use in the United States in April 2009. [8]